# Charles Brenner — Researcher persona

## Agent handoff

You are reading the markdown export of a source-grounded Researcher persona:
a corpus-backed model of a real person's public thinking. The About report
below is synthesized only from the cited sources; the Sources section lists
the provenance. For structured data (full source corpus, records, profile,
build history) fetch the JSON. To chat with the persona over its corpus, see
the agent guide.

- Persona: Charles Brenner
- Summary: Durable Researcher corpus for Charles Brenner: NAD+ metabolism research, reviews, and his public scrutiny of over-hyped longevity claims, with entity-owned source snapshots and indexes.
- Page: https://researcher.now/e/charles-brenner
- JSON: https://researcher.now/public/entities/by-slug/charles-brenner?include=all
- Sources: 129
- About report version: v3

## About

Charles Brenner’s central pattern is a disciplined refusal to let “NAD” become a free-floating longevity metaphor: he treats NAD as a concrete metabolic system made of specific coenzymes, precursor molecules, transport routes, tissue compartments, stress states, and measurable endpoints, then uses that biochemical realism to police the boundary between plausible intervention and public-health overclaim. This matters because Brenner helped create the modern NR/NAD translation field while also becoming one of its most forceful internal critics—arguing that NAD biology is real, clinically interesting, and often stress-responsive, but that biomarker increases, mouse lifespan results, celebrity protocols, and supplement marketing do not equal proven human longevity benefits [1fc4ecf0-acab-4205-9fd5-b9899d69e36b, f2f2094e-69c3-4f11-97c3-2c596928a060, 0bddd549-ab44-40da-94a7-d404c6b2de75, 466fa256-5261-4580-9dad-de60f5825c0d].

## Recurring interests and themes

- **NAD as the organizing biochemical language:** Brenner repeatedly explains metabolism through the four NAD coenzymes—NAD+, NADH, NADP+, and NADPH—as the electron-transfer machinery that converts food into ATP, biomass, repair capacity, and redox defense rather than as a generic “energy” supplement story [f6546cb5-dafd-4c01-a18e-98b92280ea57, fe53c033-a1aa-4fa8-8f96-17801059cfc8].
- **Precursor specificity over “NAD booster” lumping:** He distinguishes nicotinic acid, nicotinamide, nicotinamide riboside, NMN, and other vitamin B3-derived molecules by route, enzyme use, tissue context, side-effect profile, and evidence status, resisting marketplace equivalence among “boosters” [1fc4ecf0-acab-4205-9fd5-b9899d69e36b, f2f2094e-69c3-4f11-97c3-2c596928a060].
- **Metabolic stress as the real intervention context:** His favored use case is not “everyone is aging, therefore everyone needs NAD,” but situations where the NAD system is measurably attacked—DNA damage, inflammation, infection, overnutrition, alcohol-related liver disease, heart failure, mitochondrial disease, noise injury, postpartum remodeling, and rare metabolic disorders [53132716-b5df-4d43-9f9c-9bef90cba8ba, 466fa256-5261-4580-9dad-de60f5825c0d].
- **NR as a translational platform, not a miracle molecule:** Brenner’s work traces NR from the 2004 discovery of the NR kinase pathway to human trials showing oral bioavailability and safety, while continuing to frame health benefits as condition- and endpoint-specific rather than automatic consequences of higher NAD [3995bffe-8af7-4be5-8e9c-a2c9db277e3b, a5da65cd-1c83-44c8-a543-981a3bbf941c, f2f2094e-69c3-4f11-97c3-2c596928a060].
- **Aging hype as a scientific-integrity problem:** He treats anti-aging as a field especially prone to “fountain of youth” storytelling, celebrity scientists, selective citation, weak replication, and supplement/drug stacks that reach the public before evidence justifies them [40f0cd41-4d52-499d-b1a2-5ed64ed8c73c, 0bddd549-ab44-40da-94a7-d404c6b2de75].
- **Mechanistic disputes as public education:** His critiques of NMN transport, sirtuin longevity genes, resveratrol, rapamycin-style extrapolation, and epigenetic reprogramming are not side issues; they are recurring demonstrations of his broader rule that mechanism claims must survive chemistry, genetics, replication, and functional tests [9b06f225-ecb0-488c-88f9-a7c908f0b3d9, d5e601fe-bd14-4bfb-ae45-2ceef8d9fad3, f96749ec-7db9-4d05-b005-c8b5a2ed3fc6].
- **Quantification as epistemic discipline:** Brenner’s lab identity includes quantitative NAD metabolomics, because he sees single-marker snapshots as potentially misleading and favors full metabolome measurement across tissues, precursors, and stress conditions [80022aaf-7df8-4d99-aa03-34cb7736c2d5, 4a2974e9-8b43-4686-9621-0bd889765fbf].

## Beliefs and principles

- **Biology must obey chemistry and selection:** Brenner’s anti-myth stance rests on first principles: biological claims cannot violate chemistry or physics, and claims about conserved longevity genes must be supported by evolutionary selection and experimental conservation, not narrative analogy [252c835f-cc92-40dd-ba0d-691f0f8a1fa4].
- **Human outcomes outrank biomarkers:** He accepts NAD increases, NAAD shifts, methylated metabolites, inflammatory markers, and epigenetic clocks as useful research tools, but not as substitutes for functional or clinical outcomes in humans [64d33114-89fd-45a7-ab04-e88b9eb44b12, 466fa256-5261-4580-9dad-de60f5825c0d].
- **Aging is not a disease label to be monetized:** Brenner frames aging as a normal, complex, polygenic, environmentally shaped process and risk factor, warning that calling it a disease can pathologize life and invite poorly justified interventions in healthy people [bda7ff99-e98d-47cf-9faf-b17aca06482f, 0359b35a-4bda-4ba0-9159-75d00c38f805].
- **Public-health basics remain the strongest longevity interventions:** He repeatedly emphasizes clean water, vaccination, hygiene, nutrition, exercise, mental and social activity, and avoidance of smoking, excess alcohol, drugs, and violence over supplement-first or gene-hack narratives [64d33114-89fd-45a7-ab04-e88b9eb44b12, 0359b35a-4bda-4ba0-9159-75d00c38f805].
- **Mechanism is necessary but insufficient:** Brenner’s standard is two-step: first show a plausible and specific biochemical route, then test the intervention in randomized human studies with meaningful endpoints; animal and cell data are hypothesis-generating, not consumer proof [f2f2094e-69c3-4f11-97c3-2c596928a060, 71391685-9acb-4e85-a4d0-ddebf870bf48].
- **Scientific correction is a duty, not incivility:** He portrays himself as a “clarifier” opposing “obfuscators,” arguing that flawed but prestigious papers, media amplification, and commercialized narratives require direct public correction when they mislead patients, consumers, or investors [0359b35a-4bda-4ba0-9159-75d00c38f805, bf82e048-aabd-4a67-9bec-97f52d96d6c0].
- **Industry is legitimate only under evidentiary restraint:** Brenner accepts patents, licensing, ChromaDex/Niagen ties, and commercialization as vehicles for translation, but insists that partners should fund safety and efficacy work, disclose conflicts, and avoid unproven health or longevity claims [cc9bd0a3-581a-4c54-99c2-76a16c44b82c, 9b06f225-ecb0-488c-88f9-a7c908f0b3d9].

## Future narratives and predictions

- **Human lifespan extension claims will remain hard to prove:** Brenner doubts that NR, NMN, rapamycin-like interventions, or other “longevity drugs” can credibly be shown to extend human lifespan because trials would be infeasible, confounded, or dependent on exceptional populations such as centenarians [466fa256-5261-4580-9dad-de60f5825c0d, 71391685-9acb-4e85-a4d0-ddebf870bf48].
- **The field will shift toward disease- and function-specific endpoints:** His preferred translational future is trials in conditions with measurable NAD disruption or functional decline—peripheral artery disease walking speed, inflammation, mitochondrial disease, heart failure, COVID recovery, fatty liver, citrin deficiency—not generalized anti-aging claims [1c568b19-b45c-4e31-90bb-4c64ba77170a, 466fa256-5261-4580-9dad-de60f5825c0d].
- **NR plus exercise is a plausible next translational direction:** Brenner has suggested that combining NR/Niagen with exercise may be more productive than supplement-alone trials, because exercise is standard-of-care-like physiology and may reveal benefits in resilience or recovery endpoints [2de17fb8-8426-41eb-84c7-6942745c2be9].
- **NAD decline will be reframed as stress- and tissue-specific:** He expects the simplistic story that chronological age universally lowers NAD to give way to a more granular account in which inflammation, infection, obesity, alcoholism, mitochondrial disease, circadian disruption, and tissue compartment matter more than age alone [d9d0e3cc-95cf-4279-871e-0fd2af491b16, 71391685-9acb-4e85-a4d0-ddebf870bf48].
- **Supplement advertising will face tighter evidentiary scrutiny:** External review of Tru Niagen claims illustrates the future regulatory pressure Brenner’s own standard implies: biomarker-driven trials may support research and structure-function language, but not broad “clinically proven” claims for brain, heart, immune, anti-aging, or energy outcomes without direct evidence [0f35aeb3-a3cf-4e7e-87f0-610b57829854].
- **Epigenetic reprogramming will need safety-first maturation:** Brenner’s view of partial reprogramming is that the field may be scientifically interesting, but claims of age reversal must clear functional rejuvenation, cell-death confounding, tumor/teratoma risk, and blinded safety testing before translation [f96749ec-7db9-4d05-b005-c8b5a2ed3fc6, 64d33114-89fd-45a7-ab04-e88b9eb44b12].
- **Rare disease and metabolic mechanism will drive his next frontier:** His Helsinki-linked focus on citrin deficiency shows a likely future emphasis on using mechanistic metabolism—metabolite accumulation, ChREBP activation, fatty liver, sweet aversion, FGF21—to open targeted therapies for rare disease and broader metabolic dysfunction [4a2974e9-8b43-4686-9621-0bd889765fbf, 466fa256-5261-4580-9dad-de60f5825c0d].

## Recurring questions

- **What exactly is being raised when we “raise NAD”?** Brenner repeatedly pushes people to specify blood versus tissue NAD, NAD+ versus NADH/NADP+/NADPH, precursor versus metabolite, and whether the measured compartment is relevant to the claimed benefit [d9d0e3cc-95cf-4279-871e-0fd2af491b16, 80022aaf-7df8-4d99-aa03-34cb7736c2d5].
- **Which precursor reaches which pathway in which tissue?** A recurring Brenner question is whether NA, NAM, NR, NMN, NAR, or other precursors are biologically redundant or specialized, given differences in phosphate chemistry, transport, gut/liver conversion, enzyme expression, and tissue demand [9b06f225-ecb0-488c-88f9-a7c908f0b3d9].
- **Is the NAD system actually under attack?** He asks whether a condition shows real NAD stress—PARP activation, SARM1-mediated axon degeneration, inflammatory NAD consumption, hepatic metabolome depression, NRK induction—before proposing a precursor intervention [53132716-b5df-4d43-9f9c-9bef90cba8ba, 8f742a1c-70b3-4f40-a236-7b0309d4aa11].
- **What endpoint would convince a clinician rather than a marketer?** Brenner’s trial-design question is whether an intervention improves walking speed, blood pressure, inflammation, recovery, disease progression, safety, or function—not whether it changes an attractive biomarker [1c568b19-b45c-4e31-90bb-4c64ba77170a, 64d33114-89fd-45a7-ab04-e88b9eb44b12].
- **What did the animal model actually model?** He often interrogates whether yeast replicative lifespan, mouse drug responses, caloric restriction, dwarf mice, rapamycin, or reprogramming models plausibly translate to normal human aging rather than artifact, strain effect, trade-off, or laboratory condition [d5e601fe-bd14-4bfb-ae45-2ceef8d9fad3, f303152e-483a-4d6f-a966-8bcc0e643278].
- **Where is the replication and what were the controls?** His critiques of sirtuins, resveratrol, NMN insulin-sensitivity trials, shingles-vaccine dementia analyses, and information-theory-of-aging papers all turn on randomization, confounding, reproducibility, missing citations, and adequate controls [9b06f225-ecb0-488c-88f9-a7c908f0b3d9, 7dedbdde-7b81-481e-9f81-95bde753c2d6, 769e8065-a021-4deb-ab7d-653eb51243ff].
- **Who benefits from the story being told?** Brenner repeatedly asks how commercial incentives, book sales, venture funding, supplement marketing, prestigious journals, and social-media influence shape which aging claims get amplified and which negative results disappear [0bddd549-ab44-40da-94a7-d404c6b2de75, 40f0cd41-4d52-499d-b1a2-5ed64ed8c73c].

## Tensions and contradictions

- **Field-builder versus field-skeptic:** Brenner discovered the NR kinase pathway, helped build the NR/NAD supplement translation field, and advises ChromaDex, yet he is also one of the loudest critics of NAD-booster longevity marketing and refuses to call NR a longevity medicine [3995bffe-8af7-4be5-8e9c-a2c9db277e3b, 0359b35a-4bda-4ba0-9159-75d00c38f805].
- **Centrality of NAD versus limits of NAD claims:** He describes NAD coenzymes as central catalysts of life, but his evidentiary ethic prevents him from inferring that more NAD automatically means longer life, better health, or cellular rejuvenation in humans [f6546cb5-dafd-4c01-a18e-98b92280ea57, 466fa256-5261-4580-9dad-de60f5825c0d].
- **Commercial participation versus anti-hype policing:** His patents, stock, advisory roles, and product proximity create obvious conflict-of-interest scrutiny, while his public posture is to demand restraint, disclosure, and evidence-based claims from the very industry his discoveries enabled [cc9bd0a3-581a-4c54-99c2-76a16c44b82c, 9b06f225-ecb0-488c-88f9-a7c908f0b3d9].
- **Mechanistic optimism versus clinical conservatism:** Brenner is excited by NR in metabolic stress, postpartum remodeling, infection, heart failure, PAD, and rare disease, but he is conservative about declaring broad metabolic, wellness, or lifespan benefits when human trials show limited or mixed physiological outcomes [d24ad814-b615-41b3-a5cf-8237bd9c50fc, 7a89f5a7-5196-4233-93f3-01feafe63a93, 2e78a81e-6eb4-4ee4-82bb-754892ed2a23].
- **Public-health humility versus molecular intervention:** He emphasizes exercise, diet, sleep, vaccination, hygiene, and ordinary healthy living as the most reproducible longevity tools, while devoting his career to molecular NAD interventions in specific states of metabolic insufficiency [64d33114-89fd-45a7-ab04-e88b9eb44b12, 53132716-b5df-4d43-9f9c-9bef90cba8ba].
- **Anti-personality science through personality-driven critique:** Brenner attacks charismatic longevity narratives and “obfuscators,” but his own public influence is amplified through sharp disputes with David Sinclair, sirtuin advocates, NMN marketers, and reprogramming proponents [4cb8a913-98fc-40ae-a394-e46b0662ae98, f96749ec-7db9-4d05-b005-c8b5a2ed3fc6].
- **Skepticism of biomarkers while using metabolomics:** He warns that biomarkers are not outcomes, yet his own science depends on sophisticated NAD metabolite measurement; the reconciliation is that metabolomics can identify mechanisms and hypotheses, not automatically justify consumer health claims [80022aaf-7df8-4d99-aa03-34cb7736c2d5, 0f35aeb3-a3cf-4e7e-87f0-610b57829854].
- **Combative tone versus corrective intent:** His language can be blunt—“BS,” “obfuscators,” “fabulist,” peer-review failure—but the deeper structure is a protective one: he sees public correction as necessary when prestigious science becomes commercialized misinformation [0359b35a-4bda-4ba0-9159-75d00c38f805, 769e8065-a021-4deb-ab7d-653eb51243ff].

## Unifying threads

- **Biochemical realism is the master principle:** Across NAD metabolism, sirtuins, NMN, reprogramming, and longevity medicine, Brenner’s unifying move is to force claims back into molecules, enzymes, transport, compartments, tissues, dosing, stress states, and endpoints [1fc4ecf0-acab-4205-9fd5-b9899d69e36b, fe53c033-a1aa-4fa8-8f96-17801059cfc8].
- **Translation begins with deficiency or stress, not desire:** He is most optimistic when an intervention answers a concrete insufficiency—NAD metabolome depression, NRK induction, inflammatory PARP activation, maternal homeorhetic drain, axonal degeneration, mitochondrial disease—not a vague wish to be younger [d24ad814-b615-41b3-a5cf-8237bd9c50fc, 48cdad59-5225-42cf-8d8f-1bfed0afffab].
- **The same standard applies to friends and rivals:** Brenner criticizes NMN trials, sirtuin activation, Sinclair’s book, reprogramming papers, NAD IVs, and even weak interpretations in the NR field by asking the same questions about chemistry, controls, replication, safety, and human endpoints [9b06f225-ecb0-488c-88f9-a7c908f0b3d9, 07038dc6-b3a6-4edf-b274-ecbefa48af34].
- **He separates “aging better” from “age reversal”:** Brenner allows that lifestyle and targeted interventions may improve trajectories, resilience, inflammation, recovery, and disease-specific function, while rejecting rhetoric that presents getting healthier as reversing aging or escaping natural lifespan limits [bda7ff99-e98d-47cf-9faf-b17aca06482f, 3b966b2c-9306-43c4-b466-b07bf97fee73].
- **His public persona is an evidence-bound translator:** He is not merely a bench biochemist or supplement advocate; he converts complex metabolism into public arguments about what is known, what is plausible, what is unproven, and what may harm people if marketed too early [0bddd549-ab44-40da-94a7-d404c6b2de75, 4a2974e9-8b43-4686-9621-0bd889765fbf].
- **The long arc is from pathway discovery to responsible use:** The throughline from discovering NR as a conserved NAD precursor, to measuring NAD metabolomes, to running human safety trials, to criticizing overclaims is a coherent translational philosophy: discovery should move toward people, but only through disclosure, reproducibility, and restrained claims [3995bffe-8af7-4be5-8e9c-a2c9db277e3b, f2f2094e-69c3-4f11-97c3-2c596928a060, cc9bd0a3-581a-4c54-99c2-76a16c44b82c].

## Sources

- A Science-Based Review of the World's Best-Selling Book on Aging - ScienceDirect · brennerlab.net — https://www.brennerlab.net/wp-content/uploads/2022/09/Brenner22c.pdf
- NAD Currents | Charles Brenner, PhD | Substack · brenner.substack.com — https://brenner.substack.com/
- Thread by @CharlesMBrenner on Thread Reader App – Thread Reader App · threadreaderapp.com — https://threadreaderapp.com/thread/1411810158221488131.html
- Charles Brenner, Ph.D. | City of Hope · cityofhope.org — https://www.cityofhope.org/research/find-a-scientist/charles-brenner
- Nicotinamide riboside is uniquely and orally bioavailable in mice ... · nature.com — https://www.nature.com/articles/ncomms12948
- 119: NAD and Longevity Myths with Dr. Charles Brenner - Longevity Junky | Acast · shows.acast.com — https://shows.acast.com/longevity-junky/episodes/119-nad-and-longevity-myths-with-dr-charles-brenner
- Charles Brenner Lab | City of Hope · cityofhope.org — https://www.cityofhope.org/research/riggs-institute/diabetes-and-cancer-metabolism/charles-brenner-lab
- Sirtuins are not conserved longevity genes | Life Metabolism · academic.oup.com — https://academic.oup.com/lifemeta/article/1/2/122/6711379
- Marketers say NAD+ pills and infusions can boost longevity. What's ... · npr.org — https://www.npr.org/2026/05/11/nx-s1-5813664/nad-infusions-supplements-longevity-science
- NR pioneer: ‘I think if we combine Niagen with exercise that we’re really going to get some place’ · nutraingredients.com — https://www.nutraingredients.com/Article/2020/09/10/NR-pioneer-I-think-if-we-combine-Niagen-with-exercise-that-we-re-really-going-to-get-some-place
- Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions - PMC · pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10692436
- Full article: Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials · tandfonline.com — https://www.tandfonline.com/doi/full/10.1080/10408398.2024.2387324
- NARB decision tests limits of structure-function claims in NAD+ category · nutraingredients.com — https://www.nutraingredients.com/Article/2026/06/03/narb-decision-tests-limits-of-structure-function-claims-in-nad-category
- Firms feud over purported age-fighting molecule - C&EN · cen.acs.org — https://cen.acs.org/business/consumer-products/Firms-feud-over-Niagen-purported/96/i33
- Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns - PMC · pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC9039735
- "We won't get eternal life. Scientists who promise it are just selling ... · calcalistech.com — https://www.calcalistech.com/ctechnews/article/hy4bzl2y3
- Charles Brenner: longevity is not a simple engineering problem · longevity.technology — https://longevity.technology/news/charles-brenner-longevity-is-not-a-simple-engineering-problem
- Dr Charles Brenner on Tru Niagen, metabolism, NAD and NR · longevity.technology — https://longevity.technology/news/charles-brenner-the-journey-from-nr-to-tru-niagen
- Unpacking Longevity and the NAD Controversy | Dr Charles Brenner, PhD transcript · youtube.com — https://www.youtube.com/watch?v=hvU8ilaCIWY
- Science & Chill Ep. 42: NAD+ Metabolism & Longevity Science Controversies with Dr. Charles Brenner transcript · youtube.com — https://www.youtube.com/watch?v=8h6O5jxu6Yk
- NAD in Longevity: Breakthrough or Scam? | Dr Charles Brenner, PhD transcript · podcasts.apple.com — https://podcasts.apple.com/us/podcast/nad-in-longevity-breakthrough-or-scam-dr-charles-brenner/id1274468842?i=1000627598878
- Is longevity science overhyped? | Professor Charles Brenner, PhD · theproof.com — https://theproof.com/is-longevity-science-overhyped-professor-charles-brenner-phd
- How To Boost NAD Levels To Fight Inflammation, Improve Recovery ... · foundmyfitness.com — https://www.foundmyfitness.com/episodes/charles-brenner
- NAD and NMN with Dr. Charles Brenner - YouBoost · youboost.com — https://youboost.com/podcast/docs-who-lift-nad-and-nmn-with-dr-charles-brenner
- Ever Forward Radio with Chase Chewning: EFR 791: Why Aging is Not a Disease, Debunking Longevity Claims, SIRT 2 and SIRTUINS, the Benefits of NAD, and "Podcast Disease" with Dr. Charles Brenner · everforwardradio.libsyn.com — https://everforwardradio.libsyn.com/efr-791-why-aging-is-not-a-disease-sirt-6-and-sirtuins-the-benefits-of-nad-and-podcast-disease-with-dr-charles-brenner
- LifeBlood / Live Better and Longer with Dr. Charles Brenner · audioboom.com — https://audioboom.com/posts/8536407-live-better-and-longer-with-dr-charles-brenner
- SuperLife with Darin Olien: Dr. Charles Brenner: Debunking Longevity Myths + Using NAD+ To Age BETTER · darinolien.libsyn.com — https://darinolien.libsyn.com/dr-charles-brenner-debunking-longevity-myths-using-nad-to-age-better
- Scientists Debate How to Live Longer & Longevity Drugs | 55 - Charles Brenner — Optispan · optispan.life — https://www.optispan.life/podcast/v/9k9k3nw3r7eb4hsrf65h45rz78c62h-jg4c6
- The Case Against NAD+ IVs - Raising NAD+ (with B3 Vitamins) · raisingnad.com — https://raisingnad.com/the-case-against-nad-ivs
- Charles Brenner · drshah.com — https://www.drshah.com/extend-podcasts/charles-brenner
- [Transcript] - The New Darling Supplement Of The Anti-Aging Industry (& The Truth About Whether It Actually Works) - Ben Greenfield Life - Health, Diet, Fitness, Family & Faith · bengreenfieldlife.com — https://bengreenfieldlife.com/transcripts/transcript-new-anti-aging-supplement
- Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions · pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/37068054
- Can lifestyle hacks really extend your lifespan? - Scienceline · scienceline.org — https://scienceline.org/2024/12/longevitydebate
- Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations - PubMed · pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/35918544
- 377: Why Everything You Think About Aging May Be Wrong with Dr. Charles Brenner | Legendary Life Podcast · legendarylifepodcast.com — https://www.legendarylifepodcast.com/377-why-everything-you-think-about-aging-may-be-wrong-with-dr-charles-brenner
- Importance of NAD+ Anabolism in Metabolic, Cardiovascular and Neurodegenerative Disorders | Drugs & Aging | Springer Nature Link · link.springer.com — https://link.springer.com/article/10.1007/s40266-022-00989-0
- Emerging strategies, applications and challenges of targeting NAD+ in the clinic | Nature Aging · rdcu.be — https://rdcu.be/eMksO
- How To Boost NAD Levels To Fight Inflammation, Improve Recovery, and Slow Aging transcript · youtube.com — https://www.youtube.com/watch?v=ELcVYRJJdK4
- Matters Arising: The Information Theory of Aging Has Not Been Tested · papers.ssrn.com — https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4509193
- Why Is Mom Stressed: Homeorhesis as the Potential Problem and Nicotinamide Riboside as the Potential Solution · pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/31452603?dopt=Abstract
- NCT02689882 | "Pharmacokinetic Study of Nicotinamide Riboside" · clinicaltrials.gov — https://clinicaltrials.gov/study/NCT02689882
- The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans | Nature Metabolism · nature.com — https://www.nature.com/articles/s42255-025-01421-8
- NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence · pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/41655607
- Chronic nicotinamide riboside supplementation is well-tolerated and ... · nature.com — https://www.nature.com/articles/s41467-018-03421-7
- NAD+ metabolism in health and disease (2007) · bishtref.com — https://bishtref.com/articles/10.1016/j.tibs.2006.11.006
- The chemistry of the vitamin B3 metabolome - PMC - NIH · pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC6411094
- Nicotinamide Riboside and Nicotinic Acid Riboside Salvage ... - PMC · pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC2610512
- An Old Metabolite Controlling New Metabolic Signaling Pathways · academic.oup.com — https://academic.oup.com/edrv/article/31/2/194/2354747
- The Safety and Antiaging Effects of Nicotinamide Mononucleotide in ... · sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S2161831323013595
- Multi-omics characterization of partial chemical reprogramming ... · elifesciences.org — https://elifesciences.org/articles/90579
- Regulation of and challenges in targeting NAD+ metabolism | Nature Reviews Molecular Cell Biology · preview-www.nature.com — https://preview-www.nature.com/articles/s41580-024-00752-w
- Nicotinic Acid, Nicotinamide, and Nicotinamide Riboside: A Molecular Evaluation of NAD+ Precursor Vitamins in Human Nutrition | Annual Reviews · annualreviews.org — https://www.annualreviews.org/content/journals/10.1146/annurev.nutr.28.061807.155443
- Perspectives as Charles Brenner challenges David Sinclair on ... · ipscell.com — https://ipscell.com/2025/01/perspectives-as-charles-brenner-challenges-david-sinclair-on-longevity
- Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults. · clinicaltrials.gov — https://clinicaltrials.gov/study/NCT04910061
- BrennerSIRTSNotLongevity · brennerlab.net — https://www.brennerlab.net/wp-content/uploads/2022/06/Brenner22.pdf
- Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial | Scientific Reports | Springer Nature Link · link.springer.com — https://link.springer.com/article/10.1038/s41598-023-29787-3
- A Multicentre, Randomised, Double Blind, Parallel Design, Placebo ... · frontiersin.org — https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2022.851698/full
- NAD+-Increasing Strategies to Improve Cardiometabolic Health? · frontiersin.org — https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.815565/full
- The NADage Study: Nicotinamide Riboside Replenishment Therapy ... · clinicaltrials.gov — https://clinicaltrials.gov/study/NCT06208527
- Age reprogramming: cell rejuvenation by partial reprogramming · journals.biologists.com — https://journals.biologists.com/dev/article/149/22/dev200755/281768/Age-reprogramming-cell-rejuvenation-by-partial
- Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review | American Journal of Physiology-Endocrinology and Metabolism | American Physiological Society · journals.physiology.org — https://journals.physiology.org/doi/full/10.1152/ajpendo.00242.2023
- Targeted partial reprogramming of age-associated cell states ... · science.org — https://www.science.org/doi/10.1126/scitranslmed.adg1777
- The therapeutic perspective of NAD + precursors in age- ... · sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0006291X24001256
- A Science-Based Review of the World's Best-Selling Book on ... · pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC9669175
- Safety and Metabolism of Long-term Administration ... · nature.com — https://www.nature.com/articles/s41598-019-46120-z
- What is really known about the effects of nicotinamide riboside ... · science.org — https://www.science.org/doi/10.1126/sciadv.adi4862
- Sirtuins are not conserved longevity genes - PMC · pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10081735
- NAD + Precursors: A Questionable Redundancy · pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/35888754
- Boosting NAD to Spare Hearing · brennerlab.net — https://www.brennerlab.net/files/Brenner14c.pdf
- Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter | Nature Metabolism | Springer Nature Link · link.springer.com — https://link.springer.com/article/10.1038/s42255-019-0085-0
- Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans · pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/32320006
- An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers | PLOS One · journals.plos.org — https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0186459
- NCT05517122 · clinicaltrials.gov — https://clinicaltrials.gov/study/NCT05517122
- Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations | Cellular and Molecular Life Sciences | Springer Nature Link · link.springer.com — https://link.springer.com/article/10.1007/s00018-022-04499-5
- S0092 8674(24)00050 3 · cell.com — https://www.cell.com/cell/abstract/S0092-8674(24)00050-3
- PII: S0092-8674(04)00416-7 · brennerlab.net — https://www.brennerlab.net/files/bieganowski04a_0.pdf
- PRIME PubMed | Clinical Evidence for Targeting NAD Therapeutically · unboundmedicine.com — https://www.unboundmedicine.com/medline/citation/32942582/Clinical_Evidence_for_Targeting_NAD_Therapeutically_
- Comment on “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women” · science.org — https://www.science.org/doi/10.1126/science.abj1696
- Response to: The information theory of aging has not been tested: Cell · cell.com — https://www.cell.com/cell/fulltext/S0092-8674(24)00051-5
- Is the Longevity Field Overhyped? Charles Brenner—NAD Metabolomics Pioneer and Aging Realist - Rapamycin Longevity News · rapamycin.news — https://www.rapamycin.news/t/is-the-longevity-field-overhyped-charles-brenner-nad-metabolomics-pioneer-and-aging-realist/21028
- Accepted Manuscript · udspace.udel.edu — https://udspace.udel.edu/server/api/core/bitstreams/762edae3-bbf5-4dce-95fb-b8fd36209688/content
- Loss of epigenetic information as a cause of mammalian aging: Cell · cell.com — https://www.cell.com/cell/fulltext/S0092-8674(22)01570-7
- Thieme E-Journals - Hormone and Metabolic Research / Abstract · thieme-connect.com — https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-2382-6829
- Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies · mdpi-res.com — https://mdpi-res.com/d_attachment/antioxidants/antioxidants-11-01637/article_deploy/antioxidants-11-01637.pdf?version=1661320179
- A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects · brennerlab.net — https://www.brennerlab.net/files/dollerup18.pdf
- Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns · researchspace.auckland.ac.nz — https://researchspace.auckland.ac.nz/server/api/core/bitstreams/c889ef4d-a492-4d71-ad0e-bcf0535899fa/content
- It is Not Age That Lowers NAD - It is This! | Dr Charles Brenner transcript · youtube.com — https://www.youtube.com/watch?v=hDSuVz0ltl8
- The Longevity Skeptic - Nautilus · nautil.us — https://nautil.us/the-longevity-skeptic-305806
- Dr. Charles Brenner on the Surprising Science of Aging · ehealthradio.podbean.com — https://ehealthradio.podbean.com/e/dr-charles-brenner-on-the-surprising-science-of-aging
- Podcast Episode 259 - Charles Brenner - A4M · a4m.com — https://www.a4m.com/podcast-episode-259-charles-brenner.html
- NCT03151239 | Effect of "Nicotinamide Mononucleotide" (NMN) on ... · clinicaltrials.gov — https://clinicaltrials.gov/study/NCT03151239
- IHMC STEM-Talk Episode 81 with Charles Brenner · ihmc.us — https://www.ihmc.us/stemtalk/episode-81
- First human clinical trial for nicotinamide riboside - EurekAlert! · eurekalert.org — https://www.eurekalert.org/news-releases/690982
- Introducing Dr. Charles Brenner - Forever curious and passionate ... · helsinki.fi — https://www.helsinki.fi/en/news/rare-disease/introducing-dr-charles-brenner-forever-curious-and-passionate-uncharted-research-questions
- Charles Brenner, PhD (@CharlesMBrenner) / Posts / X - Twitter · x.com — https://x.com/CharlesMBrenner?lang=en
- Nicotinamide mononucleotide (NMN) as an anti-aging health product · sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S2090123221001491
- Marketers say NAD+ pills and infusions can boost longevity. What's ... · houstonpublicmedia.org — https://www.houstonpublicmedia.org/npr/2026/05/11/nx-s1-5813664/marketers-say-nad-pills-and-infusions-can-boost-longevity-whats-the-evidence
- Scientist Challenges David Sinclair's Best-Selling Book on Aging · nad.com — https://www.nad.com/news/charles-brenner-critiques-david-sinclairs-best-selling-book-on-aging
- Is the Longevity Field Overhyped? Charles Brenner—NAD Metabolomics Pioneer and Aging Realist transcript · youtube.com — https://www.youtube.com/watch?v=3s5QCHOsfB0
- 63. Charles Brenner: NAD, Energy, and Longevity: The Secret Nobody Told You About transcript · podcasts.apple.com — https://podcasts.apple.com/us/podcast/63-charles-brenner-nad-energy-and-longevity-the/id1773578243?i=1000709109219&l=fr-FR

_+29 more sources. Page the full corpus via the JSON export (`?include=all&sourcesOffset=…`)._

---

Structured data: https://researcher.now/public/entities/by-slug/charles-brenner?include=all
Agent guide: https://researcher.now/agent.txt